MEI Pharma (MEIP) Short Interest Ratio & Short Volume → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free MEIP Stock Alerts $3.25 0.00 (0.00%) (As of 04/19/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability MEI Pharma Short Interest DataCurrent Short Volume7,800 sharesPrevious Short Volume9,100 sharesChange Vs. Previous Month-14.29%Dollar Volume Sold Short$31,200.00Short Interest Ratio / Days to Cover0.3Last Record DateMarch 31, 2024Outstanding Shares6,663,000 sharesFloat Size6,150,000 sharesShort Percent of Float0.13%Today's Trading Volume26,402 sharesAverage Trading Volume23,334 sharesToday's Volume Vs. Average113% Short Selling MEI Pharma ? Sign up to receive the latest short interest report for MEI Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMEIP Short Interest Over TimeMEIP Days to Cover Over TimeMEIP Percentage of Float Shorted Over Time Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> MEI Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20247,800 shares $31,200.00 -14.3%0.1%0.3 $4.00 3/15/20249,100 shares $34,853.00 -27.2%0.2%0.4 $3.83 2/29/202412,500 shares $51,875.00 +23.8%0.2%0.4 $4.15 2/15/202410,100 shares $46,157.00 -97.0%0.2%0.3 $4.57 1/31/2024331,500 shares $1.49 million -1.1%5.4%7 $4.50 1/15/2024335,200 shares $1.94 million -0.7%5.5%6.7 $5.80 Get the Latest News and Ratings for MEIP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MEI Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023337,500 shares $1.96 million -7.5%5.5%6.9 $5.80 12/15/2023365,000 shares $2.31 million -5.7%5.9%7.1 $6.33 11/30/2023386,900 shares $2.38 million -2.8%6.3%6.6 $6.14 11/15/2023398,100 shares $3.12 million -25.7%6.5%7.4 $7.84 10/31/2023536,100 shares $3.66 million +7.4%8.9%13 $6.82 10/15/2023499,000 shares $3.34 million +18.8%8.2%12.4 $6.70 9/30/2023419,900 shares $2.94 million +57.3%6.9%9.1 $7.01 9/15/2023267,000 shares $1.38 million +3.6%4.4%6.1 $5.18 8/31/2023257,700 shares $1.37 million -29.8%4.3%7 $5.32 8/15/2023367,300 shares $2.57 million +16.0%6.1%7.9 $7.00 7/31/2023316,700 shares $2.24 million +1.1%5.2%5.7 $7.07 7/15/2023313,200 shares $2.33 million -4.7%5.2%4.8 $7.44 6/30/2023328,700 shares $2.16 million +2.3%5.4%5.1 $6.58 6/15/2023321,300 shares $2.37 million +5.6%5.3%4.8 $7.38 5/31/2023304,400 shares $2.34 million +28.4%5.0%4.2 $7.70 5/15/2023237,100 shares $1.69 million -14.7%3.9%2.9 $7.11 4/30/2023277,900 shares $1.41 million +17.7%4.6%3.8 $5.09 4/15/2023236,100 shares $1.13 million -95.6%3.9%3.9 $4.80 3/31/20235,340,000 shares $1.22 million +1.3%N/A5 $0.23 3/15/20235,270,000 shares $1.32 million +20.9%N/A4.7 $0.25 2/28/20234,360,000 shares $968,792.00 +0.9%N/A3 $0.22 2/15/20234,320,000 shares $1.31 million +24.1%N/A3.2 $0.30 1/31/20233,480,000 shares $992,496.00 -23.7%N/A2.8 $0.29 1/15/20234,560,000 shares $1.49 million +19.4%N/A3.6 $0.33 12/30/20223,820,000 shares $930,552.00 +11.7%N/A3 $0.24 12/15/20223,420,000 shares $837,900.00 -25.3%N/A2.7 $0.25 11/30/20224,580,000 shares $1.56 million +4.8%N/A3.9 $0.34 11/15/20224,370,000 shares $1.51 million -13.3%N/A5.9 $0.34 10/31/20225,040,000 shares $1.71 million +2.7%N/A6.8 $0.34 10/15/20224,910,000 shares $1.85 million +4.9%N/A6.1 $0.38 9/30/20224,680,000 shares $1.81 million +0.7%N/A5.1 $0.39 9/15/20224,650,000 shares $2.32 million -0.6%N/A2.9 $0.50 8/31/20224,680,000 shares $2.37 million -7.9%N/A2.1 $0.51 8/15/20225,080,000 shares $2.94 million -9.1%N/A1.6 $0.58Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story MEIP Short Interest - Frequently Asked Questions What is MEI Pharma's current short interest? Short interest is the volume of MEI Pharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 7,800 shares of MEIP short. 0.13% of MEI Pharma's shares are currently sold short. Learn More on MEI Pharma's current short interest. Which institutional investors are shorting MEI Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of MEI Pharma: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for MEI Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.13% of MEI Pharma's floating shares are currently sold short. Is MEI Pharma's short interest increasing or decreasing? MEI Pharma saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 7,800 shares, a drop of 14.3% from the previous total of 9,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MEI Pharma's float size? MEI Pharma currently has issued a total of 6,663,000 shares. Some of MEI Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MEI Pharma currently has a public float of 6,150,000 shares. How does MEI Pharma's short interest compare to its competitors? 0.13% of MEI Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to MEI Pharma: Synlogic, Inc. (0.63%), Onconova Therapeutics, Inc. (0.12%), Lumos Pharma, Inc. (5.94%), Cumberland Pharmaceuticals Inc. (0.21%), Biora Therapeutics, Inc. (4.16%), Vincerx Pharma, Inc. (5.94%), NeuroSense Therapeutics Ltd. (0.70%), FSD Pharma Inc. (2.06%), Bullfrog AI Holdings, Inc. (6.78%), BioVie Inc. (3.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short MEI Pharma stock? Short selling MEIP is an investing strategy that aims to generate trading profit from MEI Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MEI Pharma? A short squeeze for MEI Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MEIP, which in turn drives the price of the stock up even further. How often is MEI Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEIP, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: SYBX Short Squeeze ONTX Short Squeeze LUMO Short Squeeze CPIX Short Squeeze BIOR Short Squeeze VINC Short Squeeze NRSN Short Squeeze HUGE Short Squeeze BFRG Short Squeeze BIVI Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MEIP) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlace1970’s computer coder issues shocking A.I. warningTradeSmithHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends